Tomás-Bort, E., Kieler, M., Sharma, S., Candido, J. B. & Loessner, D. 3D approaches to model the tumor microenvironment of pancreatic cancer. Theranostics 10, 5074–5089 (2020).
Fischbach, C. et al. Engineering tumors with 3D scaffolds. Nat. Methods 4, 855–860 (2007).
Loessner, D. et al. A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns. Biomaterials 190–191, 63–75 (2019).
Loessner, D. et al. Bioengineered 3D platform to explore cell–ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 31, 8494–8506 (2010).
Loessner, D. et al. Functionalization, preparation and use of cell-laden gelatin methacryloyl-based hydrogels as modular tissue culture platforms. Nat. Protoc. 11, 727–746 (2016).
Hedegaard, C. L. et al. Peptide-protein coassembling matrices as a biomimetic 3D model of ovarian cancer. Sci. Adv. 6, eabb3298 (2020).
Osuna de la Peña, D. et al. Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology. Nat. Commun. 12, 5623 (2021).
Kast, V. et al. A tumor microenvironment model of pancreatic cancer to elucidate responses toward immunotherapy. Adv. Healthc. Mater. https://doi.org/10.1002/adhm.202201907 (2022).
Loessner, D. et al. A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread. Biomaterials 34, 7389–7400 (2013).
Holzapfel, B. M. et al. Species-specific homing mechanisms of human prostate cancer metastasis in tissue engineered bone. Biomaterials 35, 4108–4115 (2014).
DelNero, P. et al. 3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways. Biomaterials 55, 110–118 (2015).
Bray, L. J. et al. Multi-parametric hydrogels support 3D in vitro bioengineered microenvironment models of tumour angiogenesis. Biomaterials 53, 609–620 (2015).
Taubenberger, A. V. et al. 3D extracellular matrix interactions modulate tumour cell growth, invasion and angiogenesis in engineered tumour microenvironments. Acta Biomater. 36, 73–85 (2016).
Malacrida, B. et al. A human multi-cellular model shows how platelets drive production of diseased extracellular matrix and tissue invasion. iScience 24, 102676 (2021).
Colombo, M. V. et al. Engineering the early bone metastatic niche through human vascularized immuno bone minitissues. Biofabrication 13, 035036 (2021).
Sameni, M. et al. MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression. J. Vis. Exp. https://doi.org/10.3791/3661 (2012).
Sameni, M. et al. Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situ. Breast Cancer Res. 19, 56 (2017).
Gjorevski, N. et al. Designer matrices for intestinal stem cell and organoid culture. Nature 539, 560–564 (2016).
Liu, A. P. et al. The living interface between synthetic biology and biomaterial design. Nat. Mater. 21, 390–397 (2022).
Hutmacher, D. W. et al. Convergence of regenerative medicine and synthetic biology to develop standardized and validated models of human diseases with clinical relevance. Curr. Opin. Biotechnol. 35, 127–132 (2015).
Ingber, D. E. Reverse engineering human pathophysiology with organs-on-chips. Cell 164, 1105–1109 (2016).
Simian, M. & Bissell, M. J. Organoids: a historical perspective of thinking in three dimensions. J. Cell Biol. 216, 31–40 (2017).
Albritton, J. L. & Miller, J. S. 3D bioprinting: improving in vitro models of metastasis with heterogeneous tumor microenvironments. Dis. Model. Mech. 10, 3–14 (2017).
Weiden, J., Tel, J. & Figdor, C. G. Synthetic immune niches for cancer immunotherapy. Nat. Rev. Immunol. 18, 212–219 (2018).
Liu, H.-Y., Korc, M. & Lin, C.-C. Biomimetic and enzyme-responsive dynamic hydrogels for studying cell–matrix interactions in pancreatic ductal adenocarcinoma. Biomaterials 160, 24–36 (2018).
Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31–46 (2022).
Labani-Motlagh, A., Ashja-Mahdavi, M. & Loskog, A. The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses. Front. Immunol. 11, 940 (2020).
Cox, T. R. The matrix in cancer. Nat. Rev. Cancer 21, 217–238 (2021).
Pearce, O. M. T. et al. Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers. Cancer Discov. 8, 304–319 (2018).
Grünwald, B. T. et al. Spatially confined sub-tumor microenvironments in pancreatic cancer. Cell 184, 5577–5592.e18 (2021).
Below, C. R. et al. A microenvironment-inspired synthetic three-dimensional model for pancreatic ductal adenocarcinoma organoids. Nat. Mater. 21, 110–119 (2022).
Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812–830.e14 (2018).
Duan, Q., Zhang, H., Zheng, J. & Zhang, L. Turning cold into hot: firing up the tumor microenvironment. Trends Cancer 6, 605–618 (2020).
Tian, C. et al. Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells. Proc. Natl Acad. Sci. USA 116, 19609 (2019).
Rice, A. J. et al. Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cells. Oncogenesis 6, e352 (2017).
Choi, S. et al. Intrafibrillar, bone-mimetic collagen mineralization regulates breast cancer cell adhesion and migration. Biomaterials 198, 95–106 (2019).
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J. & Werb, Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat. Commun. 11, 5120 (2020).
Xu, K. et al. 3D porous chitosan-alginate scaffold stiffness promotes differential responses in prostate cancer cell lines. Biomaterials 217, 119311 (2019).
Yue, X., Nguyen, T. D., Zellmer, V., Zhang, S. & Zorlutuna, P. Stromal cell-laden 3D hydrogel microwell arrays as tumor microenvironment model for studying stiffness dependent stromal cell–cancer interactions. Biomaterials 170, 37–48 (2018).
Ling, L. et al. Obesity-associated adipose stromal cells promote breast cancer invasion through direct cell contact and ECM remodeling. Adv. Funct. Mater. 30, 1910650 (2020).
Srinivasan, S., Kryza, T., Batra, J. & Clements, J. Remodelling of the tumour microenvironment by the kallikrein-related peptidases. Nat. Rev. Cancer 22, 223–238 (2022).
Candido, J. B. et al. Kallikrein-related peptidase 6 is associated with the tumour microenvironment of pancreatic ductal adenocarcinoma. Cancers 13, 3969 (2021).
Loessner, D. et al. Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer. Exp. Opin. Ther. Targets 22, 745–763 (2018).
Wang, Z. et al. 3D-organoid culture supports differentiation of human CAR(+) iPSCs into highly functional CAR T cells. Cell Stem Cell 29, 515–527.e18 (2022).
Steele, N. G. et al. Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer. Nat. Cancer 1, 1097–1112 (2020).
Bear, A. S., Vonderheide, R. H. & O’Hara, M. H. Challenges and opportunities for pancreatic cancer immunotherapy. Cancer Cell 38, 788–802 (2020).
留言 (0)